Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Citric acid trilithium salt tetrahydrate (Lithium citrate tribasic tetrahydrate) , the active component of Lithium, is a medicine used in the therapy of psychiatric disease. It has shown the effects of signaling pathways and metabolic in the brain based on the particular disease and clinical condition model. According to the reports, Citric acid trilithium salt tetrahydrate was used as a mood stabilizer when treating bipolar mood disorders (BD) and lower the risk of self-harm in BD patient. In addition,Citric acid trilithium salt tetrahydrate has been the choice drug in the therapy of acute manic episodes.Citric acid trilithium salt tetrahydrate also could dissolve uric acid crystals in urine achieved from patients with gout. Besides,Citric acid trilithium salt tetrahydrate have some dose-dependent side-effects. The the main side-effects of Lithium Citrate is the tendency to inhibit the prostatic acid phosphatase enzyme (PAP), which result in the accumulation of PAP.
説明 | Citric acid trilithium salt tetrahydrate (Lithium citrate tribasic tetrahydrate) , the active component of Lithium, is a medicine used in the therapy of psychiatric disease. It has shown the effects of signaling pathways and metabolic in the brain based on the particular disease and clinical condition model. According to the reports, Citric acid trilithium salt tetrahydrate was used as a mood stabilizer when treating bipolar mood disorders (BD) and lower the risk of self-harm in BD patient. In addition,Citric acid trilithium salt tetrahydrate has been the choice drug in the therapy of acute manic episodes.Citric acid trilithium salt tetrahydrate also could dissolve uric acid crystals in urine achieved from patients with gout. Besides,Citric acid trilithium salt tetrahydrate have some dose-dependent side-effects. The the main side-effects of Lithium Citrate is the tendency to inhibit the prostatic acid phosphatase enzyme (PAP), which result in the accumulation of PAP. |
別名 | Lithium citrate tribasic tetrahydrate, Trilithium citrate tetrahydrate |
分子量 | 281.98 |
分子式 | C6H13Li3O11 |
CAS No. | 6080-58-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 52 mg/mL (184.4 mM)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: 51 mg/mL (180.9 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Citric acid trilithium salt tetrahydrate 6080-58-6 Chromatin/Epigenetic Metabolism Microbiology/Virology Neuroscience PI3K/Akt/mTOR signaling Stem Cells GSK-3 Dehydrogenase HIF/HIF Prolyl-Hydroxylase Antibacterial GluR HIF-1α Lithium citrate tribasic tetrahydrate HIF-PH Lithium citrate tribasic Tetrahydrate Citrate CaOx ACLY ATP Citrate Lyase Litarex tetrahydrate Trilithium citrate Tetrahydrate HIFs Lithium citrate tetrahydrate cleavage Bacterial Trilithium citrate tetrahydrate Hypoxia-inducible factors Lithium citrate tribasic stones extramitochondrial antioxidation Citric acid trilithium Tetrahydrate Trilithium Citrate inhibit ATP Inhibitor anti-inflammation Citric acid safety inhibitor